The company struggled to IPO but got public in late 2010 with a major valuation haircut (fraction of cash invested) as the only way to feed a very high burn rate supporting its formulation improvement for a generic migraine drug.
America is productive enough that it could probably shelter, feed, educate, and even provide health care for its entire population with just a fraction of us actually working.